Document is current

Any future updates will be listed below

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Crossref DOI link: https://doi.org/10.1007/s40268-017-0203-y

Published Online: 2017-08-11

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark